Interventional Therapeutic Trials
Non-Interventional Epidemiology , Observational , and Outcomes Studies
Total Patients Enrolled on Trials
Hamasaki ’ s oncologist , UH Cancer Center researcher , Jared Acoba , MD , suggested he participate in the Lung-MAP study , or the Lung Cancer Master Protocol , a precision medicine clinical trial for people with advanced non-small cell lung cancer that has continued to grow after treatment . Hamasaki received a MEDI4736 infusion every 14 days . After participating in the year-long clinical trial , Hamasaki returned to the standard immunotherapy treatment and his condition remained under control .
Through Hamasaki ’ s strong will and guidance from Dr . Acoba , his condition improved , and he has been off immunotherapy for the past two years .
I BELIEVE THE CHANCE TO PARTICIPATE IN THIS CLINICAL TRIAL IS PART OF THE REASON I AM ALIVE TODAY . I WOULD RECOMMEND ENROLLING IN A CLINICAL TRIAL , AS IT IS YOUR CHANCE TO HELP AND IMPROVE THE TREATMENT OF CANCER .”
“ I believe the chance to participate in this clinical trial is part of the reason I am alive today . I would recommend enrolling in a clinical trial , as it is your chance to help and improve the treatment of cancer ,” said Hamasaki .
Clinical trials are research studies designed to test the safety and effectiveness of new treatments for cancer and are a key focus of the UH Cancer Center . Patients who enroll onto clinical trials play a significant role in the discovery of new and better ways to prevent , detect , and treat cancer .
The mortality rate of cancer is falling , in large part due to clinical trials . The UH Cancer Center ’ s 20BY25 campaign seeks to increase awareness about the importance of cancer clinical trials through public education . The goal is to enroll 20 percent of all individuals with newly diagnosed and relapsed cancers onto clinical trials by the year 2025 .
RICKY HAMASAKI
13